- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
The Challenges, Opportunities for Severe Pulmonary Regurgitation Treatment
Wayne B. Batchelor, M.D., Associate Director of Inova Heart and Vascular Institute, discusses the latest advancements in less invasive techniques for treating pulmonary regurgitation.
Batchelor, an associate director of Inova Heart and Vascular Institute, discusses the latest advancements in less invasive techniques for treating severe pulmonary regurgitation (SPR).
SPR is a condition that affects one of the valves in the heart in patients often in their early part of life or are born into adulthood. SPR can also result from problems that develop during adulthood.
Batchelor recalled the challenges, historically affecting SPR, have been around treatment.
Treating this condition usually has required open heart surgery, which can be more invasive.
However, there are new developments that have made their way into the space over the last few years that offer less invasive techniques to fix pulmonary valves that are leaky.
One of the latest developments in the space is the Harmony TPV, or the Medtronic Harmony™ Transcatheter Pulmonary Valve, which Inova was granted as one of the first hospitals to use the tool in commercial settings after it was FDA approved.
Lack of Diversity in Clinical Trials Hurts Research, and Costs Billions | AHA Scientific Sessions
November 12th 2023Healthcare researchers say it’s critical to get more women, Black and Latino participants in clinical trials. It can be done, but researchers and institutions must make the effort.
Read More
Study Predicts Alarming Increase in Cardiovascular Deaths Due to Impact of Extreme Heat
November 1st 2023Recent data found that extreme heat is projected to lead to a significantly higher burden of excess cardiovascular deaths in the United States by midcentury (2036–2065), with elderly adults and non-Hispanic Black adults being most affected.
Read More
